Loading...
7733 logo

Olympus CorporationTSE:7733 Stock Report

Market Cap JP¥2.3t
Share Price
JP¥2.08k
n/a
1Y-11.6%
7D0.7%
Portfolio Value
​
View

Olympus Corporation

TSE:7733 Stock Report

Market Cap: JP¥2.3t

Olympus (7733) Stock Overview

Manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. More details

7733 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Rewards

Earnings are forecast to grow 11.04% per year

Earnings grew by 11.4% over the past year

Risk Analysis

No risks detected for 7733 from our risk checks.

7733 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

7733 logo
Olympus

Digital And Robotic Endoscopy Will Serve A Growing Aging Market

Key Takeaways Olympus' innovation pipeline and structural reforms position it for accelerated growth, margin expansion, and significant market share gains beyond current analyst expectations. Advancements in robotics, recurring services, and digital solutions strengthen its ability to capture long-term, above-market growth in minimally invasive medical procedures.
View narrative
JP¥3k
FV
30.7% undervalued intrinsic discount
5.14%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7733 logo
Olympus

7733: Market Will Weigh Product Recall Against Modest Guidance Revision Risk

Key Takeaways Reorganization into customer-focused divisions and new product launches are set to improve efficiency, increase market penetration, and enhance revenue and margins. Local manufacturing in China and FDA clearance in the U.S. bolster market share, with initiatives like Project Elevate strengthening global medtech position.
View narrative
JP¥2.08k
FV
0.04% overvalued intrinsic discount
4.44%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
7733 logo
Olympus

Austerity Policies And FDA Alerts Will Trigger Price Erosion

Key Takeaways Shifting healthcare policies and increased regulatory scrutiny are squeezing Olympus' revenue streams, profitability, and escalating compliance and legal risks. Heavy dependence on core endoscopy and resistance to industry trends expose Olympus to market disruptions, price erosion, and long-term earnings volatility.
View narrative
JP¥1.66k
FV
25.2% overvalued intrinsic discount
2.39%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
View Stock Community

Olympus Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Olympus
Historical stock prices
Current Share PriceJP¥2,078.50
52 Week HighJP¥2,415.00
52 Week LowJP¥1,443.00
Beta0.34
1 Month Change11.06%
3 Month Change13.49%
1 Year Change-11.55%
3 Year Change-22.14%
5 Year Change-3.37%
Change since IPO520.45%

Recent News & Updates

Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00

Dec 08
Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00

Olympus' (TSE:7733) Upcoming Dividend Will Be Larger Than Last Year's

Nov 24
Olympus' (TSE:7733) Upcoming Dividend Will Be Larger Than Last Year's

Recent updates

Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00

Dec 08
Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00

Olympus' (TSE:7733) Upcoming Dividend Will Be Larger Than Last Year's

Nov 24
Olympus' (TSE:7733) Upcoming Dividend Will Be Larger Than Last Year's

Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00

Nov 10
Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00

Olympus (TSE:7733) Might Have The Makings Of A Multi-Bagger

Sep 30
Olympus (TSE:7733) Might Have The Makings Of A Multi-Bagger

Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

Aug 12
Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jul 25
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Jul 09
Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price

Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Jun 17
Olympus (TSE:7733) Seems To Use Debt Quite Sensibly

Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 16
Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?

Apr 22
Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?

The Returns At Olympus (TSE:7733) Aren't Growing

Apr 07
The Returns At Olympus (TSE:7733) Aren't Growing

Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects

Mar 22
Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects

These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well

A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)

Jan 17
A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)
User avatar

Cloud-Powered Endoscopy Innovation Fuels Revenue Growth In The Medical Devices Industry

Approval of AI endoscopy devices in the U.S. and Europe is expected to drive revenue growth through improved clinical outcomes and procedural efficiency.

Shareholder Returns

7733JP Medical EquipmentJP Market
7D0.7%-0.2%-0.6%
1Y-11.6%-6.2%22.3%

Return vs Industry: 7733 underperformed the JP Medical Equipment industry which returned -6.2% over the past year.

Return vs Market: 7733 underperformed the JP Market which returned 22.3% over the past year.

Price Volatility

Is 7733's price volatile compared to industry and market?
7733 volatility
7733 Average Weekly Movement4.9%
Medical Equipment Industry Average Movement3.3%
Market Average Movement3.8%
10% most volatile stocks in JP Market8.1%
10% least volatile stocks in JP Market2.0%

Stable Share Price: 7733 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 7733's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
191929,297Bob Whitewww.olympus.co.jp

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platforms, and AI insights and computer-aided detection/diagnosis products; reprocessing products, such as endoscope reprocessors, chemicals, accessories, and peripherals; and medical services, which include repair center services.

Olympus Corporation Fundamentals Summary

How do Olympus's earnings and revenue compare to its market cap?
7733 fundamental statistics
Market capJP¥2.29t
Earnings (TTM)JP¥97.72b
Revenue (TTM)JP¥977.65b
23.4x
P/E Ratio
2.3x
P/S Ratio

Is 7733 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7733 income statement (TTM)
RevenueJP¥977.65b
Cost of RevenueJP¥320.48b
Gross ProfitJP¥657.17b
Other ExpensesJP¥559.45b
EarningsJP¥97.72b

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

Feb 13, 2026

Earnings per share (EPS)88.75
Gross Margin67.22%
Net Profit Margin10.00%
Debt/Equity Ratio31.9%

How did 7733 perform over the long term?

See historical performance and comparison

Dividends

1.4%
Current Dividend Yield
23%
Payout Ratio

Does 7733 pay a reliable dividends?

See 7733 dividend history and benchmarks
When do you need to buy 7733 by to receive an upcoming dividend?
Olympus dividend dates
Ex Dividend DateMar 30 2026
Dividend Pay DateJun 05 2026
Days until Ex dividend111 days
Days until Dividend pay date178 days

Does 7733 pay a reliable dividends?

See 7733 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/08 23:11
End of Day Share Price 2025/12/08 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Olympus Corporation is covered by 28 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Warren LauAletheia Analyst Network Limited
Masahiro NakanomyoBarclays
Ritsuo WatanabeBofA Global Research